Case Studies

As the leading provider of generic contrast agents, Fresenius Kabi’s commitment is to provide you with choice and value – by continuing to grow their radiology portfolio. We look forward to seeing you at RSNA 2025 | Booth #3247 | South Hall 

Canon Medical is launching new X-ray advances at the Radiological Society of North America (RSNA) 2025 annual meeting.

Pulmonary embolism (PE) treatment has evolved over time, yet it remains the third leading cause of cardiovascular death across the United States. TriStar Health, a comprehensive health system serving Tennessee and Kentucky and part of HCA Healthcare, is now using an AI platform to support clinicians in providing more effective care for PE patients.

Six years ago, two radiologists with dissimilar backgrounds and divergent clinical interests put their heads together and launched a new practice. One physician was an academic subspecialized in musculoskeletal reads. The other, a private practitioner, concentrated on oncologic imaging. That’s how Transparent Imaging was born, powered by Konica Minolta. 

Identifying the signs of severe aortic stenosis is typically a fairly straightforward process for cardiologists. In some cases, however, the patient’s symptoms present in a way that is outside of the norm. 

Prosthesis-patient mismatch (PPM) is the phenomenon that occurs when the effective orifice area of a prosthetic heart valve isn’t adequately sized to meet a patient’s blood flow requirements. More is known today about PPM than ever before—but there is still so much to learn. 

In a private dining room in Miami, something unusual is happening. Leaders from competing imaging centers are openly discussing their best practices—even sharing vendor recommendations and operational strategies that have doubled their volumes while cutting costs in half.

Pulmonary embolism (PE) remains one of the leading causes of cardiovascular death in the United States. TriStar Health, part of HCA Healthcare, has made PE a priority by bringing together a multidisciplinary team and adopting AI-enabled workflows to support timely diagnosis and treatment. This approach is designed to drive consistent, high-quality care – whether patients are seen at a large hospital or a community ER.

Market-savvy radiologists recognize the shortage of talent in their profession as a challenging yet exciting opportunity. More patients and referrers are ready to be served—and greater compensation is ripe to be earned.  

Atrial fibrillation (AFib), the most common heart rhythm disorder, continues to rise globally - it is predicted to affect more than 12 million people in the US by 2030 and almost 18 million people in Europe by 2060. With a growing aging population and an increased prevalence of heart disease, the demand for effective treatments for AFib is higher than ever before. 

Nearly 120 million adults in the United States have hypertension, and just 1 in 4 of them have it under control. Treatments remain limited outside of lifestyle changes and hypertensive medications that are not always effective.  

Many if not most healthcare AI vendors market tweaked versions of large language models developed by other, usually larger companies. The lack of originality isn’t just a superficial concern. It may burden adopting healthcare organizations with practical, clinical and even legal risks. For clients of the radiology technology company CIVIE, formerly known as Collaborative Imaging, those worries are soon to be things of the past.